Lagmitaf Tablet 30's

Lagmitaf Tablet 30's is used in the treatment of Human Immunodeficiency Virus (HIV) Infection. The detailed uses of Lagmitaf Tablet 30's are as follows:

• Treatment of HIV-1 infection in adults and adolescents: Lagmitaf Tablet 30's is used for managing HIV-1 infection in adults and children weighing 25 kg or more, either as a first-line antiretroviral therapy or as a replacement for a stable regimen in patients with no history of treatment failure.
• Suppression of viral replication: Lagmitaf Tablet 30's works by preventing the virus from multiplying in the body, helping to reduce the viral load to undetectable levels.
• Improvement of immune function: By controlling the virus, Lagmitaf Tablet 30's allows the immune system to recover and function more effectively, reducing the risk of HIV-related complications.

Lagmitaf Tablet 30's is a combination of Bictegravir, Emtricitabine and Tenofovir. It works by inhibiting the HIV reverse transcriptase enzymes necessary for the virus's DNA reproduction. This causes inhibition of DNA replication and thereby prevents further spread of infection. Lagmitaf Tablet 30's helps reduce the symptoms, control the infection, and prevent opportunistic infections effectively. It also helps in improving the quality of life of a patient with HIV. 

• Take Lagmitaf Tablet 30's with or without food or as advised by a doctor.
• Follow your doctor's instructions on the dosage and timing of this medication, to ensure the safety.
• Swallow the medicine as a whole with a glass of water.
• Do not crush, break, or chew it.

• Eat a healthy and balanced diet. Eat vitamin and nutrient-rich food such as vegetables and fruit as it helps to boost your immune system. Try to take lean protein and whole grains.
• Avoid eating raw meat and eggs. Consume properly boiled and cooked meat, poultry or seafood.
• Eat bland and low-fat foods, and avoid spicy or oily foods if you experience nausea or vomiting.
• Get tested for other sexually transmitted infections, such as gonorrhoea or syphilis.
• Try to reduce emotional and physical stress by spending time with your family or doing whatever makes you happy.
• Drink more fluids and avoid alcoholic beverages to prevent dehydration.  
• Never share personal items with body fluids or blood on them, such as razor blades or toothbrushes.
• Avoid sharing used needles, other injection or drug equipment.

Lagmitaf Tablet 30's should be avoided if you are allergic to it. This medicine is contraindicated in patients with severe hepatic impairment, hepatitis B infection and a combination of other HIV medicines. Inform your doctor about your medical history and the medicines you take to prevent possible interactions. Lagmitaf Tablet 30's is known you cause fatal or non-fatal hepatotoxicity and skin disorders. Hence, careful monitoring should be done during the first 18 weeks of the treatment initiation. If the patient develops any signs or symptoms of hepatitis, increased transaminase, rash, or hypersensitivity reactions, Lagmitaf Tablet 30's should be discontinued immediately. This medicine may cause dizziness; hence, avoid driving or operating machines while taking Lagmitaf Tablet 30's. Before taking this medicine, inform your doctor if you have liver/kidney diseases, hypersensitivity reactions, Stevens-Johnson syndrome, cirrhosis, or hepatic fibrosis. If pregnant and breastfeeding, inform your doctor before taking Lagmitaf Tablet 30's. Lagmitaf Tablet 30's should be used in children only if recommended by the doctor. If prescribed, the child should be carefully monitored for any changes. Lagmitaf Tablet 30's treats the infection but does not cure or prevent it.